PMV Pharmaceuticals Statistics
Total Valuation
PMVP has a market cap or net worth of $107.77 million. The enterprise value is -$77.96 million.
Market Cap | 107.77M |
Enterprise Value | -77.96M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PMVP has 51.44 million shares outstanding. The number of shares has increased by 12.39% in one year.
Shares Outstanding | 51.44M |
Shares Change (YoY) | +12.39% |
Shares Change (QoQ) | +0.11% |
Owned by Insiders (%) | 2.61% |
Owned by Institutions (%) | 92.21% |
Float | 40.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.51 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.79, with a Debt / Equity ratio of 0.06.
Current Ratio | 16.79 |
Quick Ratio | n/a |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.10% and return on invested capital (ROIC) is -34.06%.
Return on Equity (ROE) | -29.10% |
Return on Assets (ROA) | -26.20% |
Return on Capital (ROIC) | -34.06% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.03M |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, PMVP has paid $3,000 in taxes.
Income Tax | 3,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.83% in the last 52 weeks. The beta is 1.55, so PMVP's price volatility has been higher than the market average.
Beta (1Y) | 1.55 |
52-Week Price Change | -62.83% |
50-Day Moving Average | 1.78 |
200-Day Moving Average | 3.15 |
Relative Strength Index (RSI) | 61.71 |
Average Volume (30 Days) | 573,200 |
Short Selling Information
The latest short interest is 2.82 million, so 5.48% of the outstanding shares have been sold short.
Short Interest | 2.82M |
Short Previous Month | 2.78M |
Short % of Shares Out | 5.48% |
Short % of Float | 6.96% |
Short Ratio (days to cover) | 6.22 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -76.87M |
Pretax Income | -65.10M |
Net Income | -65.10M |
EBITDA | -64.02M |
EBIT | -65.10M |
Earnings Per Share (EPS) | -$1.33 |
Balance Sheet
The company has $198.76 million in cash and $13.02 million in debt, giving a net cash position of $185.74 million or $3.61 per share.
Cash & Cash Equivalents | 198.76M |
Total Debt | 13.02M |
Net Cash | 185.74M |
Net Cash Per Share | $3.61 |
Equity / Book Value | 212.68M |
Book Value Per Share | 4.13 |
Working Capital | 190.40M |
Cash Flow
In the last 12 months, operating cash flow was -$56.83 million and capital expenditures -$1.40 million, giving a free cash flow of -$58.23 million.
Operating Cash Flow | -56.83M |
Capital Expenditures | -1.40M |
Free Cash Flow | -58.23M |
FCF Per Share | -$1.13 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PMVP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.39% |
Shareholder Yield | -12.39% |
Earnings Yield | -60.41% |
FCF Yield | -54.03% |
Analyst Forecast
The average price target for PMVP is $5.75, which is 173.81% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.75 |
Price Target Difference | 173.81% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |